PHATHOM PHARMACEUTICALS, INC. (PHAT) Revenue 2022–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$175.1MFY2025 · since FY2022: $0 → $175.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $175.1M | +216.9% |
| FY2024 | $55.3M | +8001.5% |
| FY2023 | $682,000 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT Net incomePHAT Net marginPHAT Gross profitPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →